Caixin Global’s Top Stories of the Month newsletter brings you the most popular news coverage over the past month. You can opt in now and get it delivered to your inbox each month for free.
As China has shifted away from its tough “zero-Covid” strategy, a massive wave of infections is overwhelming the country’s hospitals, which face shortages of health workers, ICU beds and other medical resources. Demand for Pfizer’s Paxlovid has skyrocketed, but limited domestic supplies of the drug have led Chinese patients to turn to overseas straw buyers.
